Trust no one.
Interest in medicinal use for psychedelics is exponentiating within the confines of American consciousness. Perhaps successes in medical cannabis aided the humble psychedelics to transcend cultural stigma, but that’s less important.
What’s important is compounds like LSD and psilocybin have qualities besides medical benefits. Namely, the psychedelic experience: a journey through the self, outer world and, some report, those beyond. Psychedelic research oftentimes introduces scientists to a “god-line” separating simple medical curiosity, and “the other”. How is western– particularly American–science to navigate the god-line? Is our culture prepared for the consequences of crossing it?
The DEA has announced the scheduling of Kratom, a southeast Asian plant used extensively in traditional medicine, to Schedule 1 beginning 30 September. According to the DEA website, “Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse.”
Kratom, a plant native to Southeast Asian countries like Thailand, has long been used in traditional medicine. Advocates claim the substance has great potential to mitigate the effects of opioid addiction and in the treatment of chronic pain, which is typically treated now with opioid drugs like Oxycodone.
The cryptic hacker Guccifer 2.0 continues to pour forth a diverse stream of ever evolving democratic party leaks. After revealing the party’s favoring of Hillary Clinton, emails now disclose messages from the alcohol lobby. Give you one guess what about–opposition to cannabis reform.
Mary Jane’s medical and recreational success in Colorado has opened up the airwaves to all sorts of debate. Even those pushing to peel the plant’s schedule 1 status away were curious if it could integrate into society. Driving laws came into immediate question, and how to detect and handle stoned drivers.